Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity

Diabetes

Volumn 63, Issue 6, 2014, Pages 2158-2171

  Dimas, Antigone S ^a,b   Lagou, Vasiliki ^a,c   Barker, Adam ^d   Knowles, Joshua W ^e   Mägi, Reedik ^a,c,f   Hivert, Marie France ^g,h   Benazzo, Andrea ⁱ   Rybin, Denis ^j   Jackson, Anne U ^k   Stringham, Heather M ^k   Song, Ci ^l,m   Fischer Rosinsky, Antje ⁿ   Welløv Boesgaard, Trine ^o   Grarup, Niels ^p   Abbasi, Fahim A ^e   Assimes, Themistocles L ^e   Hao, Ke ^q   Yang, Xia ^r   Lecoeur, Cécile ^s   Barroso, Inês ^t,u   Bonnycastle, Lori L ^v   Böttcher, Yvonne ^w   Bumpstead, Suzannah ^t   Chines, Peter S ^b   Erdos, Michael R ^v   Graessler, Jurgen ^x   Kovacs, Peter ^w   Morken, Mario A ^v   Narisu, Narisu ^v   Payne, Felicity ^t   Stancakova, Alena ^y   Swift, Amy J ^v   Tönjes, Anke ^w,z   Bornstein, Stefan R ^x   Cauchi, Stéphane ^s   Froguel, Philippe ^s,aa   Meyre, David ^s,ab   Schwarz, Peter E H ^x   Häring, Hans Ulrich ^ac   Smith, Ulf ^ad   Boehnke, Michael ^k   Bergman, Richard N ^ae   Collins, Francis S ^v   Mohlke, Karen L ^af   Tuomilehto, Jaakko ^ag,ah,ai   Quertemous, Thomas ^e   Lind, Lars ^aj   Hansen, Torben ^p,ak   Pedersen, Oluf ^p,al,am,an   Walker, Mark ^ao   Pfeiffer, Andreas F H ^n,ap   Spranger, Joachim ⁿ   Stumvoll, Michael ^w,z   Meigs, James B ^h,aq   Wareham, Nicholas J ^d   Kuusisto, Johanna ^y   Laakso, Markku ^y   Langenberg, Claudia ^d   Dupuis, Josée ^j,ar   Watanabe, Richard M ^ae   Florez, Jose C ^h,aq,as   Ingelsson, Erik ^a,l   McCarthy, Mark I ^a,c,at   Prokopenko, Inga ^a,c,aa   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TARTU   (Estonia)

^g UNIVERSITÉ DE SHERBROOKE   (Canada)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY OF FERRARA   (Italy)

^j BOSTON UNIVERSITY   (United States)

^k UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^l UPPSALA UNIVERSITY   (Sweden)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^o STENO DIABETES CENTER   (Denmark)

^p Capital Region   (Denmark)

^q MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s INSTITUT PASTEUR DE LILLE   (France)

^t WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^w UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^x DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^y KUOPIO UNIVERSITY HOSPITAL   (Finland)

^z UNIVERSITY OF LEIPZIG   (Germany)

^aa IMPERIAL COLLEGE LONDON   (United Kingdom)

^ab MCMASTER UNIVERSITY   (Canada)

^ac UNIVERSITY OF TÜBINGEN   (Germany)

^ad UNIVERSITY OF GOTHENBURG   (Sweden)

^ae UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^af UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^ag NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ah DANUBE UNIVERSITY KREMS   (Austria)

^ai KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^aj UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^ak UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^al HAGEDORN RESEARCH INSTITUTE   (Denmark)

^am UNIVERSITY OF COPENHAGEN   (Denmark)

^an AARHUS UNIVERSITY   (Denmark)

^ao NEWCASTLE UNIVERSITY   (United Kingdom)

^ap GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^aq HARVARD MEDICAL SCHOOL   (United States)

^ar FRAMINGHAM HEART STUDY   (United States)

^as BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^at CHURCHILL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PROINSULIN;

ARAP1 GENE; ARTICLE; CDKAL1 GENE; CDKN2A GENE; CDKN2B GENE; GCK GENE; GCKR GENE; GENE; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HHEX IDE GENE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; IRS1 GENE; KLF14 GENE; META ANALYSIS (TOPIC); MTNR1B GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PPARG GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; SLC30A8 GENE; TCF7L2 GENE;

ALLELES; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 84901298851     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0949     Document Type: Article

References (44)

1. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365:1333-1346
2. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC Investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through largescale association analysis. Nat Genet 2010;42:579-589
3. Morris AP, Voight BF, Teslovich TM, et al.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-990
4. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC Investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105- 116
5. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 2010;1212:59-77
6. Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008;51:1100-1110
7. Strawbridge RJ, Dupuis J, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; MuTHER Consortium; CARDIoGRAM Consortium; C4D Consortium. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 2011;60:2624-2634
8. Ashcroft FM, Rorsman P. Diabetes mellitus and the b cell: the last ten years. Cell 2012;148:1160-1171
9. Banasik K, Hollensted M, Andersson E, et al. The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals. BMC Med Genet 2012;13:10
10. Grarup N, Overvad M, Sparsø T, et al. The diabetogenic VPS13C/C2CD4A/ C2CD4B rs7172432 variant impairs glucose-stimulated insulin response in 5,722 non-diabetic Danish individuals. Diabetologia 2011;54:789-794
11. Jonsson A, Ladenvall C, Ahluwalia TS, et al. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on a- and β-cell function and insulin action in man. Diabetes 2013;62:2978-2983
12. Nielsen T, Sparsø T, Grarup N, et al.; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release. Diabetologia 2011;54:1052-1056
13. Wagner R, Dudziak K, Herzberg-Schäfer SA, et al. Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin. PLoS One 2011;6:e23639
14. Ingelsson E, Langenberg C, Hivert MF, et al.; MAGIC Investigators. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 2010;59:1266- 1275
15. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16:895-906 (Pubitemid 28367943)
16. Manning AK, Hivert MF, Scott RA, et al.; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium; Multiple Tissue Human Expression Resource (MUTHER) Consortium. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-669
17. Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998; 63:134-141 (Pubitemid 28453331)
18. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301 (Pubitemid 30131733)
19. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470 (Pubitemid 29418240)
20. Gutt M, Davis CL, Spitzer SB, et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 2000;47: 177-184
21. Fall T, Hägg S, Mägi R, et al.; European Network for Genetic and Genomic Epidemiology (ENGAGE) consortium. The role of adiposity in cardiometabolic traits: a mendelian randomization analysis. PLoS Med 2013;10:e1001474
22. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-894 (Pubitemid 46764279)
23. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-1320
24. Mägi R, Morris AP. GWAMA: software for genome-wide association metaanalysis. BMC Bioinformatics 2010;11:288
25. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191
26. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009;41:77-81
27. Zeggini E, Scott LJ, Saxena R, et al.; Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40:638-645
28. Everitt BS, Landau S, Leese M. Cluster Analysis. 4th ed. London, Arnold, 2001
29. Shimodaira H. Approximately unbiased tests of regions using multistepmultiscale bootstrap resampling. Ann Stat 2004;32:2616-2641 (Pubitemid 40936685)
30. Calinski T, Harabasz J. A dendrite method for cluster analysis. Commun Stat 1974;3:1-27
31. González-Sánchez JL, Martínez-Larrad MT, Zabena C, Pérez-Barba M, Serrano-Ríos M. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. Diabetologia 2008;51:1993-1997
32. Kirchhoff K, Machicao F, Haupt A, et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008;51:597-601
33. Loos RJ, Franks PW, Francis RW, et al. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 2007;56:1943-1947 (Pubitemid 47025464)
34. Stolerman ES, Manning AK, McAteer JB, et al. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009;52:614-620
35. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009;41:82-88
36. Langenberg C, Pascoe L, Mari A, et al.; RISC Consortium. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 2009;52:1537- 1542
37. Matschinsky FM. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 2002;51(Suppl. 3):S394-S404 (Pubitemid 35403423)
38. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345:971-980
39. Simonis-Bik AM, Nijpels G, van Haeften TW, et al. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010;59:293- 301
40. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001;414:788-791 (Pubitemid 34000781)
41. Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-1849 (Pubitemid 38917250)
42. Awata T, Inoue K, Kurihara S, et al. Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. Biochem Biophys Res Commun 2000;268:612-616 (Pubitemid 30119670)
43. Small KS, Hedman AK, Grundberg E, et al.; GIANT Consortium; MAGIC Investigators; DIAGRAM Consortium; MuTHER Consortium. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet 2011;43:561-564
44. Helgason A, Pálsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39: 218-225 (Pubitemid 46184353)